Company Filing History:
Years Active: 2023
Title: Parkash Gill: Innovator in Cancer Treatment
Introduction
Parkash Gill is an innovative inventor based in the United States, known for his contributions to cancer treatment research. His work focuses on the development of humanized antibodies that target the EphB4 protein, which plays a significant role in cancer progression.
Latest Patents
Although Parkash Gill currently holds no patents, he has made significant strides in his research. His notable invention involves humanized antibodies that bind to the EphB4 protein, which can be utilized for therapeutic purposes. This invention includes a deimmunized antibody or antigen-binding fragment that targets the extracellular domain of EphB4. The heavy chain variable region comprises specific sequences, while the light chain variable region includes additional defined sequences.
Career Highlights
Parkash Gill is associated with Vasgene Therapeutics, Inc., where he contributes to groundbreaking research in cancer therapies. His work is pivotal in exploring new avenues for treatment, particularly through the use of advanced antibody technology.
Collaborations
In his professional journey, Parkash Gill collaborates with Timothy David Jones, enhancing the research efforts at Vasgene Therapeutics, Inc. Their combined expertise fosters innovation and drives the development of effective cancer treatments.
Conclusion
Parkash Gill is a dedicated inventor whose work in cancer treatment through humanized antibodies showcases his commitment to advancing medical science. His contributions, although not yet patented